Trial Profile
P05532 Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections (IFIs) in Immuncompromised Patients in Austria. Version 1, 08-Nov-2007.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions
- Acronyms WITHDRAWN
- Sponsors Merck Sharp & Dohme
- 27 Aug 2015 New trial record